Treatment for acquired apraxia of speech (AOS) has taken numerous forms, with positive outcomes reported for most treatments. Following a critical evaluation and synthesis of the AOS treatment literature, AOS treatment guideline developers concluded that "taken as a whole, the AOS treatment literature indicates that individuals with AOS may be expected to make improvements in speech production as a result of treatment, even when AOS is chronic….and the strongest evidence for this conclusion exists for treatments designed to improve articulatory kinematic aspects of speech production" (Wambaugh, Duffy, McNeil, Robin, & Rogers, 2006; p.lxii ). This conclusion was based upon general criteria concerning the overall quantity and quality of the evidence-base. Strom (2008) subsequently confirmed the positive effects of articulatory-kinematic AOS treatment approaches using meta-analysis.
and Western Aphasia Battery Aphasia Quotients (WAB-AQs; Kertesz, 1982; 2007) ranged from 14.8 to 75.5. Twenty-three of the participants were more than one year post-stroke (min-max: 8 to 259 months-post-onset).
Data Extraction
Original graphing software files were available for 17 of the participants and were used for obtaining probe values for effect size calculations. For the remaining participants, probe values were determined using published graphs.
Effect Size Calculations
Effect sizes (d-index; Bloom, Fischer, & Orme, 2003) were calculated as indications of the magnitude of change associated with treatment. Effect sizes were calculated for each target (i.e., set of items) for each participant, with separate calculations made for treated items (acquisition effects) and untreated items (generalization effects). Separate effect sizes were obtained for changes associated with treatment phases and follow-up phases.
To calculate treatment phase effect sizes, all baseline probe values for the behavior (i.e., probes conducted prior to the application of treatment for that behavior) and the final three probe values in the treatment phase were utilized. To calculate follow-up phase effect sizes, the probe values from the initial baseline phase for each behavior (i.e., probes conducted in baseline prior to the application of any treatment) and all follow-up probe values were used. The follow-up phase effect sizes reflected the cumulative effects of all phases of treatment on the behavior. (i.e., any generalization effects would be included). In cases where only one follow-up probe value was available, delta values were calculated instead of d-index values. Table 2 for each participant and are displayed by treatment target and study phase, with treated and untreated targets shown separately. Treatment targets per participant ranged from two to nine sets of items. In all but one investigation, data for untrained exemplars were available for calculation of response generalization effect sizes. Across the participants, 272 effect size calculations were performed; d-index values could not be obtained for 14 calculations due to lack of variance.
Results

Effect sizes are shown in
Acquisition Effects of SPT (effects on trained items)
In all but one instance (Wambaugh & Nessler, 2004 , one of nine trained sounds), positive effect sizes were obtained for changes associated with the treatment phase. A wide range of effect sizes was found across participants, with a minimum of d = -.18 and a maximum of d = 47.13. Wide variation was also found within participant in some cases (e.g., d = -.18 to +23.09; d = 1.8 to 23.3). However, little variation in effect sizes was found in other cases (e.g., d = 3.11 to 3.55).
Effect sizes for changes associated with the follow-up phase for trained items ranged from d= .94 to 16.84. Although follow-up effect sizes were generally smaller than treatment phase effect sizes, some participants demonstrated larger effect sizes for follow-up.
Response Generalization Effects of SPT (effect on untrained exemplars of trained items).
As with trained items, positive effect sizes were found in all but one instance for untrained items (Wambaugh et al., in press, Participant 1). Effect sizes for untrained exemplars of trained items ranged from d = -.26 to d = 22.14 for changes associated with the treatment phase. Although effect sizes for untrained items were generally smaller than effect sizes for corresponding trained items, in some cases the magnitude of change was comparable.
Effect sizes for untrained items associated with the follow-up phase ranged from d = -.82 to 20.79. For some participants, follow-up effect sizes tended to be smaller for untrained items than for trained items.
Planned Meta-Analysis
Two participants are currently completing a second and final phase of SPT (Wambaugh et al., in preparation, P3 & P4) . Effect sizes for their second treatment targets and follow-up data will also be calculated. Then, a meta-analysis of all the studies will be completed to obtain benchmarks for small, medium, and large effect sizes (e.g., first, second and third quartiles for the d-statistic; Beeson & Robey, 2006) .
Discussion
Group findings concerning the overall magnitude of change for treated items relative to untreated items will be considered relative to theories of speech production and implications for treatment application/modification. Individual participant findings will be discussed with regard to participant characteristics and treatment targets. Findings will also be discussed with respect to ramifications for AOS treatment design. n/a n/a n/a n/a n/a n/a 3.75 5.69 2.05 2.50 n/a n/a n/a n/a n/a n/a Wambaugh et al., 1999 /s/ initial, 1-syl. CV(C) words /p/ initial, 1-syl. CV(C) words /v/ initial, 1-syl. CV(C) words /k/ initial, 1-syl. CV(C) words /ʃ/ initial, 1-syl. CV(C) words /ʤ/ initial, 1-syl. CV(C) words /l/ initial, 1-syl. CV(C) words /m/ initial, 1-syl. CV(C) words /n/ initial, 1-syl. CV(C) words 17.16 * 8.86 23.09 9.10 -0.18 2.26 1.53 5.13 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 
